PMID: 11912944Mar 27, 2002Paper

Psychiatric aspects of traumatic brain injury

The Psychiatric Clinics of North America
Vani Rao, Constantine G Lyketsos

Abstract

TBI is a complex heterogenous disease that can produce a variety of psychiatric disturbances, ranging from subtle deficits in cognition, mood, and behavior to severe disturbances that cause impairment in social, occupational, and interpersonal functioning. With improvement and sophistication in acute trauma care, a number of individuals are able to survive the trauma but are left with several psychiatric sequelae. It is important for psychiatrists to be aware of this entity because an increasing number of psychiatrists will be involved in the care of these patients. Treatment should be interdisciplinary and multifaceted, with the psychiatrist working in collaboration with the patient, caregiver, family, other physicians, and therapists. The goal of treatment should be to stabilize symptoms; maximize potential; minimize disability; and increase productivity socially, occupationally, and interpersonally.

References

Apr 1, 1977·Perceptual and Motor Skills·D M Gronwall
Jan 1, 1992·International Journal of Psychiatry in Medicine·H V Szymanski, R Linn
Aug 1, 1992·The British Journal of Psychiatry : the Journal of Mental Science·J Lewin, D Sumners
Feb 1, 1992·The American Journal of Psychiatry·B A WroblewskiA B Joseph
Jan 1, 1991·Psychopathology·K AchtéE Vesterinen
Jan 1, 1991·The Journal of Neuropsychiatry and Clinical Neurosciences·R S Marin
Aug 1, 1991·Journal of Clinical Psychopharmacology·C T Gualtieri
Jan 1, 1990·The American Journal of Psychiatry·R S Marin
Jan 1, 1990·Journal of Clinical and Experimental Neuropsychology·H S Levin
Jul 1, 1988·Brain Injury : [BI]·S LalJ C Grip
Jun 1, 1989·Journal of Neurology, Neurosurgery, and Psychiatry·D T StussM T Richard
Jan 1, 1985·Clinical Neuropharmacology·M R Trimble
Oct 1, 1988·Brain Injury : [BI]·C T Gualtieri, R W Evans
Oct 1, 1988·The British Journal of Psychiatry : the Journal of Mental Science·W A Lishman
Nov 1, 1987·Journal of Learning Disabilities·F C Goldstein, H S Levin
Feb 1, 1988·The American Journal of Psychiatry·R G RobinsonT R Price
Jun 1, 1987·The American Journal of Psychiatry·F S Tennant, J Wild
May 1, 1987·Annals of Neurology·R W HamillM Kelly
Aug 1, 1987·Psychiatry Research·J A Wilcox, H A Nasrallah
Oct 1, 1987·Archives of Biochemistry and Biophysics·S VadhanavikitH E Ganther
Nov 1, 1987·Journal of Neurosurgery·L M Binder
Dec 1, 1986·Brain : a Journal of Neurology·J GrafmanD Amin
Jan 1, 1987·The American Journal of Psychiatry·S ShuklaM G Miller
Feb 1, 1987·Journal of Neurosurgery·H S LevinR F Frankowski
Jan 1, 1985·Psychosomatics·J A KwentusS Kornstein
Aug 1, 1973·Psychological Medicine·W A Lishman
Apr 1, 1968·The British Journal of Psychiatry : the Journal of Mental Science·W A Lishman
Dec 1, 1983·Journal of Clinical Neuropsychology·A McLeanA R Wyler
Sep 1, 1982·Archives of Neurology·E GoldbergC A Sirio
Jun 1, 1981·Journal of Neurology, Neurosurgery, and Psychiatry·W W McKinlayM M Marshall
Jan 1, 1995·International Journal of Psychiatry in Medicine·M F Kraus
Jan 1, 1994·The Journal of Neuropsychiatry and Clinical Neurosciences·J D Duffy, J J Campbell
Jan 1, 1994·The Journal of Neuropsychiatry and Clinical Neurosciences·H Levin, M F Kraus
Nov 1, 1994·Brain Injury : [BI]·J L NickelsT M Wong
Jan 1, 1994·American Indian and Alaska Native Mental Health Research : the Journal of the National Center·S Silver

❮ Previous
Next ❯

Citations

Dec 28, 2012·Neurocritical Care·Bo WangDaniel T Laskowitz
May 11, 2005·Psychosomatics·Ryan C W HallMarcia J Chapman
Aug 1, 2012·Neural Plasticity·Craig S BudinichJoseph T McCabe
Jan 20, 2006·Brain Injury : [BI]·Elizabeth L MooreDebra A Hope
Jul 2, 2009·Psychosomatics·Sandeep VaishnaviJesse R Fann
Mar 11, 2008·Behavioral Sciences & the Law·Jessica R Gurley, David K Marcus
Apr 1, 2016·NeuroRehabilitation·Jeffrey S KreutzerHerman R Lukow Ii
May 18, 2016·Neuropsychological Rehabilitation·William CurvisNatalie Hampson
Sep 8, 2016·The Journal of Head Trauma Rehabilitation·Ali A WeinsteinLeighton Chan
Nov 28, 2013·Pharmaceuticals·David B KurlandJ Marc Simard
Oct 13, 2010·The Journal of Trauma·Panagiotis SpinosConstantine Constantoyannis
Feb 8, 2019·Frontiers in Behavioral Neuroscience·Juliana PopovitzHita Adwanikar
Jul 4, 2018·Scientific Reports·Matthew J MuelblChristopher M Olsen
Nov 26, 2010·Journal of Neuropathology and Experimental Neurology·Ashish D PatelJ Marc Simard
Dec 6, 2019·Frontiers in Neurology·Aline Silva MirandaAntônio Lúcio Teixeira
Oct 22, 2020·Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova·S G Sukiasyan, M Ya Tadevosyan

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.